SAFETY OF BARICITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA): THE 2020 INTERIM REPORT FROM ALL-CASE POST MARKETING SURVEILLANCE IN CLINICAL PRACTICE

被引：5

作者：

Fujii, T. ^{[1
]}

Atsumi, T. ^{[2
]}

Okamoto, N. ^{[3
]}

Takahashi, N. ^{[4
]}

Tamura, N. ^{[5
]}

Nakajima, A. ^{[6
,7
]}

Matsuno, H. ^{[8
]}

Tsujimoto, N. ^{[9
]}

Nishikawa, A. ^{[9
]}

Ishii, T. ^{[9
]}

Takeuchi, T. ^{[10
]}

Kuwana, M. ^{[11
]}

Takagi, M. ^{[12
]}

机构：

[1] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan

[2] Hokkaido Univ, Dept Rheumatol Endocrinol & Nephrol, Fac Med, Sapporo, Hokkaido, Japan

[3] Osaka Med Coll, Dept Rheumatol & Allergy Pediat, Takatsuki, Osaka, Japan

[4] Nagoya Univ, Grad Sch Med, Dept Orthopaed Rheumatol, Nagoya, Aichi, Japan

[5] Juntendo Univ, Dept Internal Med & Rheumatol, Sch Med, Tokyo, Japan

[6] Ueno Touseki Clin, Fukuoka, Japan

[7] Mie Univ Hosp, Ctr Rheumat Dis, Tsu, Mie, Japan

[8] Matsuno Clin Rheumat Dis, Toyama, Japan

[9] Eli Lilly Japan KK, Kobe, Hyogo, Japan

[10] Keio Univ, Div Rheumatol, Sch Med, Tokyo, Japan

[11] Nippon Med Sch, Dept Allergy & Rheumatol, Grad Sch Med, Tokyo, Japan

[12] Yamagata Univ, Dept Orthopaed Surg, Fac Med, Yamagata, Japan

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷

关键词：

D O I：

10.1136/annrheumdis-2021-eular.433

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0249

引用

页码：1150 / 1150

页数：1

共 50 条

[1] Safety of Baricitinib in Japanese Patients with Rheumatoid Arthritis (RA): The 2020 Interim Report from All-case Post Marketing Surveillance in Clinical Practice
Fujii, Takao
Atsumi, Tatsuya
Okamoto, Nami
Takahashi, Nobunori
Tamura, Naoto
Nakajima, Atsuo
Nakajima, Ayako
Matsuno, Hiroaki
Tsujimoto, Naoto
Nishikawa, Atsushi
Ishii, Taeko
Takeuchi, Tsutomu
Kuwana, Masataka
Takagi, Michiaki
[J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3489 - 3490
[2] Safety of baricitinib in Japanese patients with rheumatoid arthritis: the 2020 interim report from all-case post-marketing surveillance in clinical practice
Fujii, T.
Atsumi, T.
Okamoto, N.
Takahashi, N. T. N.
Tamura, N.
Nakajima, A.
Matsuno, H.
Tsujimoto, N.
Nishikawa, A.
Ishii, T.
Takeuchi, T.
Kuwana, M.
Takagi, M.
Larsson, E.
[J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 25 - 25
[3] Safety of Baricitinib in Patients with Rheumatoid Arthritis: Interim Report from All-Case Post-Marketing Study in Clinical Use
Atsumi, Tatsuya
Okamoto, Nami
Takahashi, Nobunori
Tamura, Naoto
Nakajima, Atsuo
Nakajima, Ayako
Fujii, Takao
Matsuno, Hiroaki
Takahashi, Yuko
Inui, Fumie
Tsujimoto, Naoto
Nishikawa, Atsushi
Ishii, Taeko
Takeuchi, Tsutomu
Kuwana, Masataka
Takagi, Michiaki
[J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
[4] Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance
Takagi, Michiaki
Atsumi, Tatsuya
Matsuno, Hiroaki
Tamura, Naoto
Fujii, Takao
Okamoto, Nami
Takahashi, Nobunori
Nakajima, Atsuo
Nakajima, Ayako
Tsujimoto, Naoto
Nishikawa, Atsushi
Ishii, Taeko
Takeuchi, Tsutomu
Kuwana, Masataka
[J]. MODERN RHEUMATOLOGY, 2023, 33 (04) : 647 - 656
[5] Infection Events in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim All-Case Post-Marketing Surveillance
Tamura, Naoto
Kuwana, Masataka
Atsumi, Tatsuya
Takei, Syuji
Harigai, Masayoshi
Fujii, Takao
Matsuno, Hiroaki
Mimori, Tsuneyo
Momohara, Shigeki
Yamamoto, Kazuhiko
Takasaki, Yoshinari
Nomura, Kazuto
Endo, Yutaka
Hirose, Tomohiro
Morishima, Yosuke
Sugiyama, Naonobu
Yoshii, Noritoshi
Takagi, Michiaki
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[6] Malignancy in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim Analysis of All-Case Post-Marketing Surveillance
Tamura, Naoto
Kuwana, Masataka
Atsumi, Tatsuya
Takei, Syuji
Harigai, Masayoshi
Fujii, Takao
Matsuno, Hiroaki
Mimori, Tsuneyo
Momohara, Shigeki
Yamamoto, Kazuhiko
Takasaki, Yoshinari
Nomura, Kazuto
Endo, Yutaka
Hirose, Tomohiro
Morishima, Yosuke
Sugiyama, Naonobu
Yoshii, Noritoshi
Takagi, Michiaki
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[7] Safety of Baricitinib Under Clinical Settings in Patients with Rheumatoid Arthritis, Using Data from All-Case Post-marketing Surveillance and Spontaneous Reports
Matsuno, Hiroaki
Atsumi, Tatsuya
Takei, Shuji
Tamura, Naoto
Harigai, Masayoshi
Fujii, Takao
Momohara, Shigeki
Takahashi, Yuko
Narii, Nobuhiro
Tsujimoto, Naoto
Nishikawa, Atsushi
Ishii, Taeko
Yamamoto, Kazuhiko
Kuwana, Masataka
Takagi, Michiaki
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[8] Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study
Okamoto, Nami
Atsumi, Tatsuya
Takagi, Michiaki
Takahashi, Nobunori
Takeuchi, Tsutomu
Tamura, Naoto
Nakajima, Atsuo
Nakajima, Ayako
Fujii, Takao
Matsuno, Hiroaki
Ishii, Taeko
Tsujimoto, Naoto
Nishikawa, Atsushi
Minatoya, Machiko
Tanaka, Yoshiya
Kuwana, Masataka
[J]. MODERN RHEUMATOLOGY, 2024,
[9] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
Tamura, N.
Kuwana, M.
Atsumi, T.
Takei, S.
Harigai, M.
Fujii, T.
Matsuno, H.
Mimori, T.
Momohara, S.
Yamamoto, K.
Nomura, K.
Endo, Y.
Sugiyama, N.
Hirose, T.
Morishima, Y.
Yoshii, N.
Takagi, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1408 - 1408
[10] Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
Mimori, Tsuneyo
Harigai, Masayoshi
Atsumi, Tatsuya
Kuwana, Masataka
Takei, Syuji
Tamura, Naoto
Fujii, Takao
Matsuno, Hiroaki
Momohara, Shigeki
Yamamoto, Kazuhiko
Kokubo, Takeshi
Endo, Yutaka
Sugiyama, Naonobu
Hirose, Tomohiro
Morishima, Yosuke
Yoshii, Noritoshi
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69

← 1 2 3 4 5 →